Shenandoah Therapeutics Inc.
South San Francisco, US · Founded 2022 · Delaware corporation · 1 known investors
Founders & leadership
MS
Mark StepkaExecutive
IG
Isabella GraefNamed on SEC filing
NG
Nathanael GrayNamed on SEC filing
Board
GY
Gary YeungBoard director
WY
Wendy YoungBoard director
JE
Jim EdwardsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 1 round · 2025
▶$21.5MraisedMay 2025 · 12 investors · Other TechnologyRule 506(b)
▶$21.5MraisedMay 2025 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark StepkaExecutive Officer
- Gary YeungDirector
- Isabella GraefExecutive Officer, Director
- Wendy YoungDirector
- Nathanael GrayDirector
- Jim EdwardsDirector
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Shenandoah Therapeutics Inc.'s investors?
- Shenandoah Therapeutics Inc.'s investors include YK Bioventures.
- How much funding has Shenandoah Therapeutics Inc. raised?
- Shenandoah Therapeutics Inc. has disclosed $21.5M raised across 1 round.
- Where is Shenandoah Therapeutics Inc. headquartered?
- Shenandoah Therapeutics Inc. is headquartered in South San Francisco, US.